<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41911">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01971424</url>
  </required_header>
  <id_info>
    <org_study_id>2011491</org_study_id>
    <nct_id>NCT01971424</nct_id>
  </id_info>
  <brief_title>Assessment of Physical Performance After Oral Supplementation of Magnesium in a Sample of Old Women in Good Health</brief_title>
  <acronym>Magnesium</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Padova</source>
  <oversight_info>
    <authority>Italy: National Bioethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Magnesium deficiency is associated also in the elderly with low physical performance;
      nevertheless trials about the effect of supplementation of magnesium on physical performance
      are not available in old people. The aim of our study is to investigate whether 12-weeks of
      oral magnesium supplementation improves physical performance in healthy elderly women
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Changes in short physical performance battery (SPPB)</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in appendicular skeletal mass (ASMMI)</measure>
    <time_frame>Baseline and after 12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Age Related Muscle Loss</condition>
  <arm_group>
    <arm_group_label>Mg oxide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants were supplemented for 12-weeks with 300 mg of daily oral magnesium oxide.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group was educated by a trained dietician to follow a healthy diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Mg oxide</intervention_name>
    <arm_group_label>Mg oxide</arm_group_label>
    <other_name>Magnesium oxide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>healthy diet</intervention_name>
    <arm_group_label>Mg oxide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  People over 65 years, not residents in nursing home, in good health

        Exclusion Criteria:

          -  previous supplementation of calcium, potassium or magnesium

          -  use of pump proton inhibitors or digitalis

          -  important co-mordidities such renal failure
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Geriatrics Division, Department of Medicine</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Dominguez LJ, Barbagallo M, Lauretani F, Bandinelli S, Bos A, Corsi AM, Simonsick EM, Ferrucci L. Magnesium and muscle performance in older persons: the InCHIANTI study. Am J Clin Nutr. 2006 Aug;84(2):419-26.</citation>
    <PMID>16895893</PMID>
  </reference>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 23, 2013</lastchanged_date>
  <firstreceived_date>October 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Padova</investigator_affiliation>
    <investigator_full_name>Giuseppe Sergi</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>magnesium</keyword>
  <keyword>SPPB</keyword>
  <keyword>strength</keyword>
  <keyword>physical performance</keyword>
  <keyword>24 hour magnesuria</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Magnesium Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
